Vagus nerve stimulation for treatment-resistant depression: behavioral and neural effects on encoding negative material
- PMID: 17244844
- PMCID: PMC2080822
- DOI: 10.1097/PSY.0b013e31802e106d
Vagus nerve stimulation for treatment-resistant depression: behavioral and neural effects on encoding negative material
Abstract
Objectives: Vagus nerve stimulation (VNS) can improve depression. Cognitive models of depression highlight an over-representation of negative thoughts and memories, with depressed individuals showing memory facilitation for negative material. We hypothesized that the antidepressant action of VNS may emerge through corrective influences on 'negativity bias' in memory. We therefore examined the impact of VNS on emotional memory and its underlying brain activity.
Methods: We tested a single patient undergoing VNS for treatment-resistant depression (TRD). Stimulation was set at a 30/66-second on/off cycle during three encoding blocks when the patient viewed randomly presented positive, negative, and neutral words. Following each block, VNS was switched off and the patient identified previously seen words from distractors in a subsequent recognition memory task. The patient was scanned using functional magnetic resonance imaging (fMRI) during the first encoding block.
Results: There was robust recall of negative material viewed during 'off' cycles of VNS but subsequent memory of negative words was attenuated during active VNS ('on' cycles). VNS did not influence memory for neutral and positive words. With neuroimaging, direct modulatory effects of VNS were observed in dorsomedial, dorsolateral, and orbital regions of the prefrontal cortex. Moreover, during encoding of negative words, compared with positive and neutral words, VNS also modulated activity within orbitofrontal, ventromedial and polar prefrontal cortices, midcingulate cortex, and brain stem.
Conclusions: Our observations show that VNS can interfere with memory of negative information, an effect that may contribute to its antidepressant role. Neuroimaging implicated regions including the ventral and medial prefrontal cortex as an underlying neural substrate.
Figures

Similar articles
-
Feasibility of vagus nerve stimulation-synchronized blood oxygenation level-dependent functional MRI.Invest Radiol. 2001 Aug;36(8):470-9. doi: 10.1097/00004424-200108000-00006. Invest Radiol. 2001. PMID: 11500598
-
Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects.J Psychiatr Res. 2002 Jul-Aug;36(4):219-27. doi: 10.1016/s0022-3956(02)00013-4. J Psychiatr Res. 2002. PMID: 12191626
-
Serial vagus nerve stimulation functional MRI in treatment-resistant depression.Neuropsychopharmacology. 2007 Aug;32(8):1649-60. doi: 10.1038/sj.npp.1301288. Epub 2007 Jan 3. Neuropsychopharmacology. 2007. PMID: 17203016 Clinical Trial.
-
A review of functional neuroimaging studies of vagus nerve stimulation (VNS).J Psychiatr Res. 2003 Nov-Dec;37(6):443-55. doi: 10.1016/s0022-3956(03)00074-8. J Psychiatr Res. 2003. PMID: 14563375 Review.
-
The application of vagus nerve stimulation and deep brain stimulation in depression.Neuropsychobiology. 2011;64(3):170-81. doi: 10.1159/000325225. Epub 2011 Jul 29. Neuropsychobiology. 2011. PMID: 21811087 Review.
Cited by
-
Psychophysiology of neural, cognitive and affective integration: fMRI and autonomic indicants.Int J Psychophysiol. 2009 Aug;73(2):88-94. doi: 10.1016/j.ijpsycho.2009.01.012. Epub 2009 May 3. Int J Psychophysiol. 2009. PMID: 19414044 Free PMC article. Review.
-
The effects of drugs on human models of emotional processing: an account of antidepressant drug treatment.Dialogues Clin Neurosci. 2015 Dec;17(4):477-87. doi: 10.31887/DCNS.2015.17.4/apringle. Dialogues Clin Neurosci. 2015. PMID: 26869848 Free PMC article. Review.
-
Autonomic balance determines the severity of COVID-19 courses.Bioelectron Med. 2020 Nov 24;6(1):22. doi: 10.1186/s42234-020-00058-0. Bioelectron Med. 2020. PMID: 33292846 Free PMC article.
-
Short-term NK1 receptor antagonism and emotional processing in healthy volunteers.Psychopharmacology (Berl). 2011 May;215(2):239-46. doi: 10.1007/s00213-010-2133-z. Epub 2010 Dec 15. Psychopharmacology (Berl). 2011. PMID: 21161182 Clinical Trial.
-
Smart Device-Driven Corticolimbic Plasticity in Cognitive-Emotional Restructuring of Space-Related Neuropsychiatric Disease and Injury.Life (Basel). 2022 Feb 4;12(2):236. doi: 10.3390/life12020236. Life (Basel). 2022. PMID: 35207523 Free PMC article. Review.
References
-
- Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, Henry TR, Collins SD, Vaughn BV, Gilmartin RC, Labar DR, Morris GL, 3rd, Salinsky MC, Osorio I, Ristanovic RK, Labiner DM, Jones JC, Murphy JV, Ney GC, Wheless JW. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology. 1998;51:48–55. - PubMed
-
- George MS, Sackeim HA, Marangell LB, Husain MM, Nahas Z, Ballenger JC, Rush AJ. Vagus nerve stimulation. A potential therapy for resistant depression? Psychiatr Clin North Am. 2000;23:757–83. - PubMed
-
- Sackheim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z, Johnson CR, Seidman S, Giller C, Haines S, Simpson RK, Jr, Goodman RR. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology. 2001;25:713–28. - PubMed
-
- Marangell LB, Rush AJ, George MS, Sackeim HA, Johnson CR, Husain MM, Nahas Z, Lisanby SH. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry. 2002;51:280–7. - PubMed
-
- Henderson LA, Richard CA, Macey PM, Runquist ML, Yu PL, Galons JP, Harper RM. Functional magnetic resonance signal changes in neural structures to baroreceptor reflex activation. J Appl Physiol. 2004;96:693–703. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical